Home
Search
Search Only:

Search Keyword study

Total: 50 results found.

Page 1 of 3
The internationally-renowned scientific journal Immunity, from the Cell Press group, published online recently, and will publish in its August 27 print issue, the results of a study conducted by a ...
  A pair of microRNAs thought to regulate immune genes are found at lower levels in the blood of those with multiple sclerosis than in unaffected individuals, according to a study appearing online ...
Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Abstract OBJECTIVE: A protective association between higher vitamin D levels and the onset of multiple sclerosis ...
... were reported in the latest Nature Neuroscience. The lead author on the study is William R. Marrs of the Neurobiology and Behavior program at the University of Washington (UW). The senior author is Dr. ...
A Home-Based Walking Program Using Rhythmic Auditory Stimulation Improves Gait Performance in Patients With Multiple Sclerosis: A Pilot Study Abstract Background. Few interventions have been successful ...
St. Joseph's Healthcare will start testing whether multiple sclerosis is a vascular disease within two weeks despite European studies questioning the controversial theory. The highly-anticipated study ...
A new study shows a gene variant may increase the severity of multiple sclerosis (MS) symptoms. The research will be published in the August 3, 2010, issue of Neurology®, the medical journal of the ...
A Menlo Park biotech firm said Friday that federal regulators will let it proceed with the world's first human test of a treatment made from embryonic stem cells, a much-anticipated but controversial study ...
UCI immunological study finds earlier way to diagnose multiple sclerosis (MS). Assessing for the increasing presence of antibodies that blocks energy production in neurons, UCI immunologists discovered ...
Glatiramer acetate and interferon beta-1a for intramuscular administration: a study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts. Abstract Objective: To study outcomes ...
Cerebellar symptoms are extremely disabling and are common in Multiple Sclerosis (MS) patients. In this feasibility study, we developed and tested a robot therapy protocol, aimed at the rehabilitation ...
Abstract The aim of this study was to examine the effectiveness of regular whole body vibration (WBV) training on lower limb muscle strength and functional mobility in individuals with multiple sclerosis. ...
Neuro-scientists from around the world are gathering at the University of Portsmouth this week. More than 80 of the world's leading specialists are attending a conference to share knowledge about the ...
... is stepping up to provide it.   “I’m working with colleagues to design a double-blinded study for assessing CCSVI and its treatment,” he said, anticipating a more extensive test ...
Abstract Objectives: Prediction of long term clinical outcome in patients with primary progressive multiple sclerosis (PPMS) using imaging has important clinical implications, but remains challenging. ...
... ties?essentially to tell readers caveat emptor, as in the Serzone study I mentioned earlier. I no longer believe that?s enough. The pharmaceutical industry devotes much, if not most, of its vast marketing ...
... says. "This study shows for the first time that specific intestinal bacteria have a significant role in affecting the nervous system during MS?and they do so from the gut, an anatomical location very, ...
... This study indicates the potential of T2*GRE and white matter?attenuated TFE sequences in ultra?high-field magnetic resonance imaging for cortical lesion detection in patients with multiple sclerosis. ...
... But do we want hopeful media reports, special interest groups and political opportunism to decide which treatments we should study, provide and insure? The idea that multiple sclerosis is caused by chronic ...
... Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, London, United Kingdom, and principal investigator of the CLARITY study. "I hope that this new therapeutic ...
«StartPrev123NextEnd»